PGY2 Oncology Pharmacy Residency Program Design
Watch this video to learn more about the design and
structure of our PGY2 Oncology Pharmacy residency Program.
The Division of Pharmacy at The University of Texas MD Anderson Cancer Center offers an ASHP accredited one-year PGY2 Oncology Pharmacy Residency Program. MD Anderson has more than 650 inpatient beds and over inpatient beds and over 5000 outpatient clinic visits daily. Residents completing the program will become competent and confident practitioners of oncology pharmacy practice. Residents will be accountable for achieving optimal drug therapy outcomes as an integral member of interdisciplinary health care teams while striving to improve the overall medication use process. They will exercise skill in oncology pharmacy operations, drug information, investigational pharmacy services, clinical research and writing, and providing education to health care professionals, patients, and the general public. Graduates from the program will be prepared to provide clinical pharmacy services for oncology, malignant hematology, and stem cell transplant patient populations in both the acute and ambulatory care settings.
Required: PharmD degree from an accredited school of pharmacy and completion of an ASHP-accredited PGY1 Pharmacy Residency Program. Texas Pharmacist licensure is required no later than October 1.
For questions regarding the program or application process, please contact Andrea Landgraf Oholendt, PharmD, BCOP Director, PGY2 Oncology Pharmacy Residency program via email PGY2-OncologyResidency@mdanderson.org or phone 713-792-4552.
Learning experiences are scheduled as monthly rotations or in a longitudinal format. Residents are required to meet with the preceptor(s) prior to starting each learning experience to review the goals/objectives and expectations of the learning experience. The resident’s daily responsibilities will be under the direction of the assigned preceptor.
Required clinical learning experiences include:
Other Required Learning Experiences
Residents will provide operations staffing in the Ambulatory Treatment Center (ATC), which will include order entry and verification, as well as chemotherapy preparation. Residents will be assigned to work approximately 20 weekends throughout the year. Residents will also provide coverage for the non-formulary on call service. Residents will be assigned to work either the Thanksgiving or Christmas Holiday (but not both). In addition, each resident will be assigned 1-2 minor holiday’s throughout the year.
The research project is an ASHP requirement and must be completed prior to completion of the residency program. The project may be administrative, clinical, or quality improvement in focus. A minimum of one preceptor will be assigned to each project to help ensure appropriateness and completion. The project should be appropriate for publication and will be presented at the HOPA annual meeting. Documentation of the research project will include a project description (including background, objectives, methods, and residents responsibilities) and a final project manuscript complete with results, data analysis, and conclusions.
Residents are required to complete a writing project during the residency. This project is separate from the research project. The purpose of the writing project is to sharpen writing skills for publication, and learn publication procedures. The writing project is typically in the form of a review article, expanded case report, or other type of manuscript and should be suitable for publication. Early in the residency year the resident will identify a topic and preceptor to work with. The preceptor’s responsibility is to assist the resident in reviewing and revising the manuscript for publication.
Presentations and Teaching Opportunities
Teaching Certificate Program
The University of Houston College of Pharmacy offers a teaching certificate program to all pharmacy residents in the Houston area. The purpose of the program is to provide a formal training program for pharmacy residents to gain knowledge and to demonstrate effectiveness in the areas of teaching, leadership and scholarship. The program consists of three components: 1) Weekly Seminars 2) Teaching Experience 3) Teaching Portfolio. This is an elective learning activity (not required).
Residents will attend the following conferences: ASHP Midyear Meeting and HOPA (Hematology/Oncology Pharmacy Association). Residents may attend other conferences designated by the program director.
What is the Goal of the Residency?
The goal of the PGY2 Oncology Pharmacy Residency Program is to provide the resident with a broad-based exposure and experience with malignant hematology, oncology, and stem cell transplant patient populations. The resident will develop his/her clinical skills and be prepared to provide clinical pharmacy services in both the acute and ambulatory care settings.
How is the Residency Offered?
The residency is a one-year program that is heavily weighted in direct patient care. The program consists of core learning experiences and additional requirements, but allows for tailored instruction on each individual resident’s interest(s) and career goals.
Is the Program Accredited by the American Society of Health-System Pharmacists?
Yes, the program received a full-cycle (6 year) re-accreditation by the Commission on Credentialing of the American Society of Health-System Pharmacists in August 2010.
Is Participation in the ASHP Match Program Required?
Participation in the ASHP match program is required. The ASHP Resident Matching Program code for the MD Anderson Oncology Residency Program is 584060. Please review match requirements and process at www.natmatch.com. For details regarding the residency application process, please visit www.mdanderson.org/pharmacy. The deadline for application submission is December 31.
How Many Resident Positions are Available and what are the Requirements?
We offer 4 Oncology Pharmacy Resident positions each year. Requirements include a PharmD degree, successful completion of an ASHP-accredited PGY1 Pharmacy Residency, and Texas Pharmacist licensure no later than October 1st.
What should I expect at the time of the On-Site Interview?
Applicants should be prepared to assume the travel and lodging costs for the interview, as MD Anderson does not have a mechanism to provide compensation for the interview. We can assist with coordinating airline and/or hotel arrangements and airport transportation if needed. The interview process entails a full day (approximately 8:00 am-5:00 pm) of meetings with clinical preceptors, administrative staff and the current residents and a tour of the facilities. During the interview, candidates will also work-up a patient case that is presented to a group of program preceptors. The purpose of the patient case is to evaluate the candidate’s knowledge base, clinical decision making skills, and communication skills. Interviews are conducted on Mondays and Fridays in January and February.
How are residents selected for the residency?
Residents are selected by the Division of Pharmacy based on multiple factors including their past education and training, letters of reference, performance during the onsite interview, and overall match with the Oncology Residency Program at MD Anderson. The program director will discuss the matching process and notification of resident selection during the on-site interview.
Does the resident need to be licensed in the state of Texas?
The resident must be eligible for pharmacist licensure in the state of Texas (reciprocity or examination) as soon they are accepted into the program. It is highly recommended that the resident complete all necessary examinations / processes for licensure prior to starting the program in July. It is mandatory that the resident is licensed by the Texas State Board of Pharmacy by October 1st in order to successfully complete the program.
Who is the PGY2 Oncology Residency Program Director and who are the preceptor faculty?
The director of the PGY2 Oncology Pharmacy Residency is Andrea Landgraf Oholendt, PharmD, BCOP. The residency coordinator is Alison Gulbis, PharmD, BCOP. In addition the Division of Pharmacy leadership and the program director, there are numerous board certified clinical pharmacy specialists who serve as preceptors for the Oncology Pharmacy Residency. This includes specialists in each of the oncology disease sites, drug information, medication safety, investigational pharmacy services, infectious diseases, and pharmacy operations. The preceptor group is dedicated and committed to the continued success of each of our residents and the program overall.
What expectations are placed on the resident?
The resident is expected to make a commitment to satisfactorily complete all requirements of the program, as planned in advance and communicated with the resident upon acceptance into the program. This commitment includes but is not limited to the following: active participation in direct patient care, presentations, weekend coverage, presentations, research and other projects as assigned, attendance at required meetings and programs, and the availability and willingness to participate in any function of the Division of Pharmacy on a 24-hour basis. The resident is required to complete documentation and evaluations for all activities and experiences and objectives accomplished. The resident must meet the criteria of “achieved” for a pre-specified number goals/objectives on order to successfully complete the program.
What are the service commitments?
In addition to scheduled and elective rotations, the resident is required to participate in weekend coverage providing pharmacy operations staffing in the Ambulatory Treatment Center (ATC). Each resident will be scheduled to work approximately every 4 weeks, including 1 major holiday (Thanksgiving or Christmas) and 1-2 minor holidays. Residents will also participate in non-formulary on call when providing weekend coverage.
What presentations and publications are expected of the resident?
Throughout the year, the resident will provide a minimum of 10 Oncology Forum presentations, 2 journal club presentations, 1 nursing inservice, and 1 program or presentation on cancer screening and prevention to the general public. Each resident is required to present “Pharmacy Grand Rounds” complete with continuing pharmacy education credit. Residents will be expected to present their research project results as a poster presentation at the annual HOPA (Hematology/Oncology Pharmacy Association) meeting. Additionally, each resident will complete a writing project for publication.
How is the resident evaluated?
The PGY2 Oncology pharmacy residency program at MD Anderson is not based upon a set number of "hours" in each experience area. Rather, it is based upon behavioral plus competency-based objectives. During each learning experience, preceptor faculty will provide the resident with weekly informal feedback as well as a formal summative evaluation upon completion of the rotation according to the pre-assigned goals and objectives. Longitudinal learning experiences are evaluated quarterly. Additionally, the resident will evaluate his/her preceptor and the learning experience upon completion of each individual experience. All learning experience evaluation are documented and maintained in PharmAcademic. Upon completion of the residency program, the resident will be asked to evaluate the residency program overall (i.e., strengths, weaknesses) as well as provide suggestions for improvement.
What support is offered for educational trips and seminars?
Every attempt is made to financially support travel for the residents to attend relevant educational seminars and programs. Priority programs include ASHP Midyear and HOPA (Hematology/Oncology Pharmacy Association) Annual Meeting.
In what other educational programs does the Division of Pharmacy participate?
The Division of Pharmacy provides case-based Shared Student Instruction for fourth year pharmacy students completing rotations at MD Anderson (approximately 3 times/year). Didactic lecture opportunities and a teaching certificate program (elective) are available through the University Of Houston College Of Pharmacy. The Division of Pharmacy provides in-service and continuing education programs to the hospital's professional staff. The Division of Pharmacy also offers additional residency programs, PGY1 Pharmacy Residency, PGY2 Critical Care Pharmacy Residency, and PGY1/PGY2 Health System Pharmacy Administration Residency).
What stipend and benefit program is offered?
The annual stipend is $55,000. The benefit program includes 10 days of vacation, 80 hours of sick leave, and comprehensive health insurance. There is no financial support for moving and living expenses, but relocation information is provided that educational trainees find very beneficial.
What other support is available to the residents during the residency?
The Division of Pharmacy provides lab coats and scrubs to the residents. An office dedicated for pharmacy residents is provided with books and supplies as well as individual desk, computer, and iPhone support. MD Anderson has its own medical library and also provides on-line access to the Texas Medical Center library both from within and outside of the institution. The institution also has its own medical graphics department to assist in the development of professional poster presentations, as well as a biostatistics department to assist with research endeavors.
What living arrangements are available for the resident?
Houston offers a wide variety of housing opportunities, including many apartments and townhouses near the Texas Medical Center. Many of the surrounding housing opportunities offer a regular shuttle service to the hospital or are close to the light rail system that goes through the Texas Medical Center
What entertainment and cultural opportunities are available in the Houston area?
Houston offers opportunities for enjoyment of the arts, entertainment, sports and recreation. The city offers major league sports, outstanding shopping areas and several special attractions, including the Johnson Space Center, Moody Gardens, the Museum of Natural Science, Cynthia Mitchell Woods Pavilion, the Toyota Center, NRG Stadium, Minute Maid Park, BBVA Compass stadium, Kemah Boardwalk, The Strand in Galveston, and the beaches of the Texas Gulf Coast.
Application Deadline and Requirements:
The following application materials must be submitted via the PhORCAS™ online application system by December 31
In addition to the Reference Form in PhORCAS™, MD Anderson also requires that your THREE References each submit a Formal Letter of Reference
2. Fax the letter to 713-792-5256 – attention Andrea Landgraf
On-site Interview Requirements and Scheduling:
Upon release of the match results, candidates that match with our institution will need to complete an institution specific application and requirements for appointment via the MD Anderson DISCOVER™ online application system. The DISCOVER System™ is a web based database utilized to streamline the application selection and appointment process. More information about this process will be provided at the time of onsite interviews.
For questions regarding the application process, please contact Andrea Landgraf Oholendt, Director PGY2 Oncology Pharmacy Residency program via email PGY2-OncologyResidency@mdanderson.org or phone (713) 792-4552.
UTMDACC does not discriminate on the basis of race, sex, color, national and ethnic origin, handicap, or age in administration of its administrative policies, admission policies, and other school administered programs. UTMDACC is a smoke-free environment.
Andrea Landgraf Oholendt, Pharm.D., BCOP
Director, PGY2 Oncology Pharmacy Residency
Division of Pharmacy
The University of Texas
MD Anderson Cancer Center
1515 Holcombe Blvd. – Unit 90
Houston, TX. 77030-4009